Abstract DNA illustration with colorful arrows on blue background

Bridging Science and Strategy from Pipeline to Launch

Services

Blurred 18-month Gantt chart with colored sticky notes, indicating project phases and tasks across Clinical, Regulatory, and CMC sections, spanning from 2023 to 2024.

Program Leadership

I work with clinical-stage teams to develop integrated drug development plans that align regulatory, clinical, and commercial priorities. By driving clarity across functions and leading through critical inflection points—including FDA interactions, protocol amendments, and trial acceleration—I help organizations navigate uncertainty and keep programs on track.

Close-up of multicolored sticky notes with handwritten text on a whiteboard.

Commercial Strategy

I support organizations in building the infrastructure, operating models, and market-shaping strategies needed to seamlessly transition from clinical development to commercialization to ensure assets reach patients successfully and sustainably.

Woman in black blazer and red pants giving a presentation in front of a dotted orange background.

Leadership Development

I design and deliver customized training and workshop experiences that build leadership capabilities across R&D, commercial, and medical teams. From strategy alignment to scenario planning and decision-making under pressure, I equip teams to lead confidently through complexity and change.

My Approach

With a patient-first mindset and an enterprise-wide lens, I partner with biotech and pharmaceutical teams to transform scientific innovation into accessible treatments. My work aligns cross-functional teams, accelerates development, and reduces risk across the drug development and launch continuum.